Answers are grounded in this paper and cite their sources.
This proof-of-concept study demonstrated the safety and efficacy of TI, at a higher modified dose conversion, when added for mealtime control to an AID system or was used for glycemic control with basal insulin.
No takes yet. Share an insight, caveat, or question.
Kaiserman et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: